Published in Arthritis Rheum on February 15, 2006
Assessing function and endurance in adults with spinal and bulbar muscular atrophy: validity of the adult myopathy assessment tool. Rehabil Res Pract (2014) 0.87
Effects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents. Arthritis Res Ther (2016) 0.80
Patient preference assessment reveals disease aspects not covered by recommended outcomes in polymyositis and dermatomyositis. ISRN Rheumatol (2011) 0.79
Intensive aerobic and muscle endurance exercise in patients with systemic sclerosis: a pilot study. BMC Res Notes (2014) 0.78
Physical impairment in patients with idiopathic inflammatory myopathies is associated with the American College of Rheumatology functional status measure. Clin Rheumatol (2014) 0.77
213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015. Neuromuscul Disord (2016) 0.76
Comparative analyses of muscle MRI and muscular function in anti-synthetase syndrome patients and matched controls: a cross-sectional study. Arthritis Res Ther (2017) 0.75
Safety and possible effects of low-intensity resistance training associated with partial blood flow restriction in polymyositis and dermatomyositis. Arthritis Res Ther (2014) 0.75
Reliability of the adult myopathy assessment tool in individuals with myositis. Arthritis Care Res (Hoboken) (2015) 0.75
Does computed tomography-based muscle density predict muscle function and health-related quality of life in patients with idiopathic inflammatory myopathies? Arthritis Care Res (Hoboken) (2015) 0.75
[Inflammatory myopathies]. Z Rheumatol (2016) 0.75
[Early symptoms of dermatomyositis and antisynthetase syndrome]. Z Rheumatol (2013) 0.75
119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord (2004) 2.85
Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum (2005) 1.89
Low serum levels of vitamin D in idiopathic inflammatory myopathies. Ann Rheum Dis (2012) 1.59
Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies. J Clin Invest (2015) 1.51
Leukocytes, cytokines, growth factors and hormones in human skeletal muscle and blood after uphill or downhill running. J Physiol (2004) 1.49
Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol (2002) 1.35
A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies. Arthritis Rheum (2007) 1.31
Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study. Arthritis Res Ther (2009) 1.29
International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Rheum (2007) 1.28
Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus. Arthritis Rheum (2003) 1.20
Pathogenesis, classification and treatment of inflammatory myopathies. Nat Rev Rheumatol (2011) 1.18
Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum (2008) 1.18
Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis. Ann Neurol (2013) 1.16
T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells. J Immunol (2009) 1.15
Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis Rheum (2013) 1.12
Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study. Arthritis Res Ther (2012) 1.11
Experiencing virtual patients in clinical learning: a phenomenological study. Adv Health Sci Educ Theory Pract (2011) 1.10
Pulmonary complications of polymyositis and dermatomyositis. Semin Respir Crit Care Med (2007) 1.10
Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis. Arthritis Rheum (2007) 1.08
Reliability and validity of the myositis disease activity assessment tool. Arthritis Rheum (2008) 1.07
Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol (2005) 1.07
Physical activity, physical fitness, and general health perception among individuals with rheumatoid arthritis. Arthritis Rheum (2005) 1.06
Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Arthritis Rheum (2004) 1.06
Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis. Arthritis Rheum (2007) 1.04
Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies. FASEB J (2009) 1.04
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford) (2010) 1.04
Reliability and feasibility of the six minute walk test in subjects with myotonic dystrophy. Neuromuscul Disord (2007) 1.02
Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Medicine (Baltimore) (2012) 0.99
The juvenile arthritis foot disability index: development and evaluation of measurement properties. J Rheumatol (2004) 0.98
Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol (2010) 0.97
Expanded T cell receptor Vβ-restricted T cells from patients with sporadic inclusion body myositis are proinflammatory and cytotoxic CD28null T cells. Arthritis Rheum (2010) 0.97
Upregulation of MHC class I in transgenic mice results in reduced force-generating capacity in slow-twitch muscle. Muscle Nerve (2009) 0.96
Individual risk factors associated with premature discharge from military service. Mil Med (2009) 0.95
Exercise as an anti-inflammatory intervention to combat inflammatory diseases of muscle. Curr Opin Rheumatol (2009) 0.94
Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies. Curr Opin Rheumatol (2012) 0.94
Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis. Arthritis Rheum (2008) 0.94
Association of the proinflammatory haplotype (MICA5.1/TNF2/TNFa2/DRB1*03) with polymyositis and dermatomyositis. Arthritis Rheum (2004) 0.94
Endothelial cell activation and neovascularization are prominent in dermatomyositis. J Autoimmune Dis (2006) 0.93
A longitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis. Mol Med (2010) 0.93
Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy. Rheumatology (Oxford) (2013) 0.92
Effects of a multiprofessional rehabilitation programme for patients with fibromyalgia syndrome. J Rehabil Med (2002) 0.91
Impaired myofibrillar function in the soleus muscle of mice with collagen-induced arthritis. Arthritis Rheum (2009) 0.91
Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers. Rheumatology (Oxford) (2009) 0.91
Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies. Arthritis Res Ther (2007) 0.90
Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction. J Rehabil Med (2003) 0.90
Restricted T cell receptor BV gene usage in the lungs and muscles of patients with idiopathic inflammatory myopathies. Arthritis Rheum (2007) 0.89
The role of TRAIL in mediating autophagy in myositis skeletal muscle: a potential nonimmune mechanism of muscle damage. Arthritis Rheum (2011) 0.87
Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial. Arthritis Rheum (2007) 0.87
TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis. Ann Rheum Dis (2012) 0.87
Pathogenesis of idiopathic inflammatory myopathies. Curr Rheumatol Rep (2006) 0.87
Cytokines in idiopathic inflammatory myopathies. Autoimmunity (2006) 0.87
Mechanical tension stimulates the transdifferentiation of fibroblasts into myofibroblasts in human burn scars. Burns (2008) 0.86
Serial analysis of Ro/SSA and La/SSB antibody levels and correlation with clinical disease activity in patients with systemic lupus erythematosus. Scand J Rheumatol (2002) 0.86
Patients with polymyositis or dermatomyositis have reduced grip force and health-related quality of life in comparison with reference values: an observational study. Rheumatology (Oxford) (2010) 0.84
Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells. Arthritis Rheum (2009) 0.84
193rd ENMC International workshop Pathology diagnosis of idiopathic inflammatory myopathies 30 November - 2 December 2012, Naarden, The Netherlands. Neuromuscul Disord (2013) 0.84
Cardiovascular disease in patients with inflammatory rheumatic disease is associated with up-regulation of markers of inflammation in cardiac microvessels and cardiomyocytes. Arthritis Rheum (2010) 0.84
New insights into the benefits of exercise for muscle health in patients with idiopathic inflammatory myositis. Curr Rheumatol Rep (2014) 0.84
Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies. Arthritis Rheum (2007) 0.84
Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up. Ann Rheum Dis (2013) 0.83
Polymyositis and dermatomyositis: pathophysiology. Rheum Dis Clin North Am (2011) 0.83
Genetically determined imbalance between serum levels of tumour necrosis factor (TNF) and interleukin (IL)-10 is associated with anti-Jo-1 and anti-Ro52 autoantibodies in patients with poly- and dermatomyositis. J Autoimmun (2006) 0.83
IVIG treatment in post-polio patients: evaluation of responders. J Neurol (2012) 0.82
Expression of APRIL in diffuse large B cell lymphomas from patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol (2011) 0.82
Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies. Ann Rheum Dis (2007) 0.82
Feasibility and effects of a physical exercise programme in adults with myotonic dystrophy type 1: a randomized controlled pilot study. J Rehabil Med (2011) 0.82
Characteristics of physiotherapy sessions from the patient's and therapist's perspective. Disabil Rehabil (2004) 0.82
Improved exercise performance and increased aerobic capacity after endurance training of patients with stable polymyositis and dermatomyositis. Arthritis Res Ther (2013) 0.81
Development of the myositis activities profile--validity and reliability of a self-administered questionnaire to assess activity limitations in patients with polymyositis/dermatomyositis. J Rheumatol (2002) 0.81
Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis. Ann Rheum Dis (2012) 0.81
Interrater reliability and aspects of validity of the myositis damage index. Ann Rheum Dis (2011) 0.81
The effects of a physical exercise programme after radical cystectomy for urinary bladder cancer. A pilot randomized controlled trial. Clin Rehabil (2013) 0.81
Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies. Autoimmun Rev (2009) 0.81
Vascular involvement in the pathogenesis of idiopathic inflammatory myopathies. Autoimmunity (2009) 0.81
Disability pension despite vocational rehabilitation? A study from six social insurance offices of a county. Int J Rehabil Res (2005) 0.81
Creatine supplementation and physical training in patients with COPD: a double blind, placebo-controlled study. Int J Chron Obstruct Pulmon Dis (2006) 0.81
Autoantibodies produced at the site of tissue damage provide evidence of humoral autoimmunity in inclusion body myositis. PLoS One (2012) 0.80
Progressive multifocal leukoencephalopathy in a patient with polymyositis: case report and literature review. J Rheumatol (2012) 0.80
Proteomic profiling reveals autoimmune targets in sarcoidosis. Am J Respir Crit Care Med (2015) 0.80
Effects of regular resistance training on muscle histopathology and morphometry in elderly patients with chronic kidney disease. Am J Phys Med Rehabil (2005) 0.80
Long-term follow-up of patients with prior polio over a 17-year period. J Rehabil Med (2016) 0.79
Quality of life in Swedish patients with post-polio syndrome with a focus on age and sex. Int J Rehabil Res (2014) 0.79
Working environmental conditions as experienced by women working despite pain. Work (2000) 0.78
Idiopathic inflammatory myopathies - myositis. Best Pract Res Clin Rheumatol (2002) 0.78
Elevated expression of prostaglandin E2 synthetic pathway in skeletal muscle of prior polio patients. J Rehabil Med (2014) 0.78
Higher pain sensitivity and lower muscle strength in postmenonpausal women with early rheumatoid arthritis compared with age-matched healthy women--a pilot study. Disabil Rehabil (2013) 0.78
Patient-reported outcomes and adult patients' disease experience in the idiopathic inflammatory myopathies. report from the OMERACT 11 Myositis Special Interest Group. J Rheumatol (2014) 0.78
Clinical symptoms in patients with myositis-an acquired metabolic myopathy? Curr Opin Rheumatol (2003) 0.77
Activated LTB4 pathway in muscle tissue of patients with polymyositis or dermatomyositis. Ann Rheum Dis (2012) 0.77
Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies. Arthritis Res Ther (2014) 0.76
Does rehabilitation decrease shoulder muscle activity in fibromyalgia in work or housework tasks? An electromyographical study. Work (2008) 0.76
Inflammatory muscle disease: clinical presentation and assessment of patients. Curr Rheumatol Rep (2007) 0.76
New possibilities to achieve increased understanding of disease mechanisms in idiopathic inflammatory myopathies. Curr Opin Rheumatol (2002) 0.76
CBA/J mice infected with Trypanosoma cruzi: an experimental model for inflammatory myopathies. Muscle Nerve (2003) 0.76
Perceived functioning and disability in adults with myotonic dystrophy type 1: a survey according to the International Classification Of Functioning, Disability and Health. J Rehabil Med (2009) 0.76
The role of exercise in the rehabilitation of idiopathic inflammatory myopathies. Curr Opin Rheumatol (2005) 0.76
Using a profile of a modified Brief ICF Core Set for chronic widespread musculoskeletal pain with qualifiers for baseline assessment in interdisciplinary pain rehabilitation. J Multidiscip Healthc (2013) 0.75
Treatment-resistant inflammatory myopathy. Best Pract Res Clin Rheumatol (2010) 0.75